Prostate cancer is one of the most common cancers affecting men worldwide. In many cases, it grows slowly and may not cause symptoms for years. However, some forms can be aggressive and spread beyond the prostate, making early detection and appropriate treatment extremely important.
Researchers continue to learn more about the genetic and biological factors that drive prostate cancer, leading to improved screening methods and more personalized treatment options. A comprehensive review of prostate cancer research highlights how advances in genetics, diagnosis, and treatment are helping improve outcomes while reducing unnecessary treatment for low-risk disease.
Understanding Prostate Cancer Risk
The prostate is a small gland located below the bladder that helps produce fluid for semen. As men age, changes in prostate cells can sometimes lead to cancer.
Several factors can increase the risk of developing prostate cancer, including:
- Older age
- Family history of prostate cancer
- Certain inherited genetic mutations
- Race and ethnicity
- Lifestyle and environmental factors
Researchers have identified several genetic changes that may contribute to prostate cancer development. Mutations in genes such as BRCA1, BRCA2, and other DNA repair genes can increase both the risk of developing prostate cancer and the likelihood of more aggressive disease.
Understanding these genetic factors is becoming increasingly important because they may influence both screening recommendations and treatment decisions.
How Prostate Cancer Is Diagnosed
One of the biggest challenges in prostate cancer care is identifying which cancers need treatment and which can be safely monitored.
Diagnosis often begins with:
- Prostate-specific antigen (PSA) testing
- Digital rectal examination (DRE)
- Imaging studies
- Prostate biopsy
PSA is a protein produced by the prostate. Elevated PSA levels may indicate prostate cancer, but they can also be caused by noncancerous conditions such as prostate enlargement or inflammation.
Because PSA testing is not perfect, doctors often combine multiple diagnostic tools to improve accuracy and reduce unnecessary procedures.
Advances in imaging and molecular testing are helping physicians better determine which cancers are likely to become dangerous and which may never cause significant health problems.
Why Not Every Prostate Cancer Needs Immediate Treatment
One of the most important developments in prostate cancer management is the growing use of active surveillance.
In the past, many men underwent surgery or radiation shortly after diagnosis. Researchers now recognize that some low-risk cancers grow so slowly that immediate treatment may not be necessary.
Active surveillance typically involves:
- Regular PSA testing
- Periodic imaging
- Follow-up biopsies when needed
This approach allows doctors to monitor the cancer closely while avoiding treatment-related side effects unless the disease begins to progress.
For many men with low-risk prostate cancer, active surveillance has become a safe and effective option.
Modern Treatment Options Continue to Expand
For patients who require treatment, there are now more options than ever before.
Traditional treatments include:
- Surgery to remove the prostate
- Radiation therapy
- Hormone therapy
In recent years, researchers have developed additional approaches that target the biology of prostate cancer more precisely.
These include:
- Targeted therapies for specific genetic mutations
- Advanced hormone-blocking medications
- Immunotherapy in selected patients
- Precision medicine approaches guided by genetic testing
The goal is to match treatments to the individual characteristics of each patient’s cancer, improving outcomes while reducing unnecessary side effects.
Lifestyle and Complementary Approaches
The review also highlights growing interest in lifestyle factors that may influence prostate health and overall well-being.
Researchers continue to study the potential role of:
- Physical activity
- Healthy dietary patterns
- Weight management
- Smoking cessation
- Stress reduction
While these approaches are not substitutes for medical treatment, maintaining overall health may help support recovery and improve quality of life during and after cancer treatment.
Patients should always discuss any complementary therapies with their healthcare team to ensure they are safe and appropriate.
The Future of Prostate Cancer Care
Prostate cancer treatment is becoming increasingly personalized. Advances in genetic testing, molecular profiling, and targeted therapies are helping doctors better predict which cancers are likely to become aggressive and which can be safely monitored.
For patients, this means more treatment options, more precise care, and a greater ability to balance cancer control with quality of life. As researchers continue to uncover the genetic drivers of prostate cancer, the future of care is likely to become even more individualized and effective.
Source
Pienta KJ, Gorin MA, Rowe SP, et al. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Cancers (Basel). 2022;14(13):3190. Accessed by: https://pmc.ncbi.nlm.nih.gov/articles/PMC9457814/
